Atopic Dermatitis Market

Atopic Dermatitis Market Size by Product Type (Corticosteroids, Calcineurin Inhibitors, Emollients/Moisturizers, Antibiotics, IL-4 and PDE4 Inhibitors, and Others), Route of Administration (Oral, Topical, and Parenteral), Distribution Channel, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-13158
  • Published Date: Dec, 2022
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global atopic dermatitis market is expected to grow from USD 10.32 billion in 2022 to USD 22.62 billion by 2030, at a CAGR of 10.31% from 2022-2030. The Asia Pacific is expected to grow the fastest during the forecast period.

Market Introduction:

An individual with atopic dermatitis experiences the impulse to scratch their skin because itching is so terrible for the body or the skin. Atopic dermatitis is also known as eczema. Any area of the body, primarily the epidermis, becomes extremely itchy, red, and dry. Dry weather, damp climate, metal allergies, food allergens, and personal care products with chemicals are just a few causes of skin itchiness. However, atopic dermatitis is most commonly found in patients with a family history of the same. Allergens also trigger it in personal care products, cosmetics, metals or foods. Environmental triggers like dampness in the air and dry and cold weather can also cause atopic dermatitis. Atopic dermatitis can be restricted to one part of the body, or it can happen to multiple parts of the body. It usually occurs behind the knee, arms or between toes. When the condition is not too severe, atopic dermatitis can be self-treated by avoiding allergens, scratching, and keeping the skin clean and hydrated. Pruritus therapies or biologics are the names of the drugs used to treat atopic dermatitis. Atopic dermatitis can be self-diagnosed and treated with a few over-the-counter drugs available in the market, like corticosteroid creams, calcineurin inhibitors, emollients/moisturizers, and antibiotics. Atopic dermatitis can be managed by avoiding chemical personal care and cosmetics, scratching, moisturizing the skin and staying hydrated. Pruritus therapies or biologics are the names of the drugs used to treat atopic dermatitis. Among the drugs that can lessen the discomfort of atopic dermatitis are topical steroids, antihistamines, corticosteroid creams, calcineurin inhibitors, emollients/moisturizers, antibiotics, IL-4 and PDE4 Inhibitors and others. Antihistamines, for instance, are used to treat atopic contact dermatitis, which is typically brought on by an allergen such as a metal like nickel.

Atopic Dermatitis Market Size

Get an overview of this study by requesting a free sample

Recent Development

November 2022 - The terms of the marketing authorization for LEO Pharma's Adtralza have been modified to include the treatment of adolescent patients between the ages of 12 and 17. The conditions for treatment include patients who have moderate-to-severe atopic dermatitis (AD) and are candidates for systemic therapy. This change has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC). The timing of the approval is crucial since, in the UK, 6% of adolescents in the newly approved age range have atopic dermatitis or one out of every five kids. There is a significant unmet need to assist patients with moderate-to-severe AD to manage AD with well-tolerated and efficient medications because moderate-to-severe AD has been found to take a physical, psychosocial, and emotional toll on adolescent patients. The phase 3 ECZTRA 6 trial data are the basis for the EC and MHRA approvals, which are valid in all European Union member states.

November 2022 - According to two phases and three trials, roxolitinib cream showed efficacy and tolerability in patients with atopic dermatitis over 44 weeks of as-needed treatment. In two double-blind phases, three studies of ruxolitinib for treating AD, long-term safety (LTS) and effectiveness data were evaluated. Patients had to be at least 12 years old, have had AD for more than two years, and have an IGA score of 2 or 3. Patients had 3% to 20% of their body's surface affected, excluding the scalp. After 44-week LTS treatment, the researchers claim that the condition was under control. 74.1% to 77.8% of patients received an IGA score of 0/1.

Market Dynamics:

Drivers:

The growing incidence of skin disorders – About 900 million people worldwide have some sort of skin disease, according to a World Health Organization report on the rising prevalence of skin diseases in 2018. Atopic dermatitis is amongst the top skin conditions that equally affect both males and females. The underlying causes of atopic dermatitis are not known. However, an individual suffering from the condition, more often than not, has a family history of the same. The condition is triggered after the skin comes into contact with certain chemicals used in personal care products or certain environmental factors, such as extremely dry winters. Numerous skin illnesses and diseases are now more common among the world's population due to the increasing incidence of harsh environmental conditions. For instance, the extremely dry winters are one of the most common causes that trigger atopic dermatitis. People with atopic dermatitis are also rising as chemicals are used more frequently in personal care and cosmetics. The disease's rising prevalence will drive the global atopic dermatitis market. The market will grow due to people becoming more knowledgeable about atopic dermatitis, its causes, and potential treatments.

Restraints:

Inadequate understanding of the causes of atopic dermatitisThe underlying triggers or exact causes can range from food allergies and chemical allergens to family history and environmental conditions. The underlying evidence about whom the disease affects the most and how it is diagnosed or differentiated from other skin conditions is insufficient. More needs to be done for the patient population. The lack of proper understanding can restrict the market's growth as high costs are poured into developing drugs that may become ineffective or cause undesirable and severe side effects. This eventually hampers brand reputation by increasing product recalls and further limiting the global atopic dermatitis market’s growth.

Opportunities:

Market players are developing novel biologics, and advanced treatment options - The increased need for atopic dermatitis medicines has prompted private companies to spend more money on developing novel drugs and therapies. Due to the increasing prevalence of skin illnesses and disorders worldwide, prominent market participants have developed promising and efficient medications to capitalize on the expanding atopic dermatitis market. Furthermore, the rising incidence and prevalence of atopic dermatitis due to cosmetics and personal care allergens or environmental triggers have convinced regulatory bodies to speed up drug approvals to offer citizens novel healthcare services. The market for atopic dermatitis treatments will expand due to regulatory approvals becoming more uniform and efficient. The development of the market will also be fueled by numerous mergers, acquisitions, and partnerships for developing medicines. The favourable reimbursement policies initiated by fiscal bodies will also expand the market in the future.

Challenges:

Stringent regulatory approvals and guidelines – The pharmaceutical and healthcare sector are subject to extremely strict rules and regulations, given their sensitive and crucial nature in the global economy and the direct impact it has on their consumers. For instance, approval and introduction of a novel drug without proper trials and checks can lead to undesirable consequences that can be fatal to consumers. As much as it is important to fast-track approval processes, it is equally vital to thoroughly check the risks and benefits associated with these drugs to safeguard consumer interests. As a result, strict regulations apply to the testing, production, distribution, and consumption of atopic dermatitis drugs, therapies and treatments. The government's strict controls will hamper the market's expansion.

Segmentation Analysis:

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the largest global atopic dermatitis market, with a 42.23% market revenue share in 2022. The United States of America dominates the North American market and is anticipated to continue its dominance during the forecast period. The development of effective and promising drugs/therapies for treating atopic dermatitis, given the presence of significant and top market players in the region, facilitates the market's growth. The North American market will be driven by the rising private capital investment in the research & development of new treatments to address the expanding demand for atopic dermatitis treatments. The market for atopic dermatitis will benefit from favourable government policies supporting expanding the pharmaceutical and healthcare industries. The well-established healthcare system makes treatments accessible and inexpensive for the populace, which supports market growth. Due to the government's increased spending on the healthcare industry due to the pandemic, the Asia Pacific market is anticipated to grow during the forecast period. Major participants in the atopic dermatitis treatment market will be drawn to the region, fueling its growth in the projected period with the development of the healthcare infrastructure and the country's sizable population.

North America Region Atopic Dermatitis Market Share in 2022 - 42.23%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product type segment analysis

The product type segment is divided into corticosteroids, calcineurin inhibitors, emollients/moisturizers, antibiotics, IL-4 and PDE4 Inhibitors, and others. The corticosteroids segment dominated the market with a revenue share of around 30% in 2022. An example of an anti-inflammatory medicine is corticosteroids. They are used to soothe the patient and lessen inflammation. Common corticosteroids include cortisone, prednisolone, dexamethasone, and hydrocortisone. Additionally, corticosteroids lessen allergic responses, swelling, itching, and redness. They are applied to numerous types of atopic dermatitis. Because of their adaptability and broad applicability, corticosteroids are a common atopic dermatitis treatment, which accounts for their market domination. They are supplied without a prescription at several drug stores. The rising awareness about corticosteroids and their increased accessibility will further the market segment's development.

Route of administration segment analysis

The route of administration segment is divided into oral, topical, and parenteral. The topical segment dominated the market with a market share of around 54% in 2022. "Topical medication" refers to drugs applied directly to the skin. Typically, they are sold as creams, gels, foams, and lotions. Topical therapies are preferable since atopic dermatitis is a skin ailment that results in irritation and discomfort on the skin's outer surface. One of the factors contributing to topical drugs' commercial domination is the simplicity and adaptability of their use. The topical route of administration allows for the avoidance of the negative effects.

Distribution channel segment analysis

The distribution channel segment is divided into hospital pharmacies, online pharmacies, retail pharmacies, and others. The retail pharmacies segment dominated the market with a market share of around 46% in 2022. The increasing number of supermarket pharmacies facilitates the expansion of the industry. Drugs for atopic dermatitis that don't require a prescription are widely available, which increases the demand for retail pharmacies. Retail pharmacies' accessibility has a big impact on the segment's growth.

Some of the Key Market Players:

  • AbbVie Inc.
  • Allergan Plc.
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb
  • Eli Lily and Company
  • Galderma laboratories LP
  • Novartis Pharmaceuticals Corporation
  • Pfizer
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA

Report Description: 

Attribute Description
Market size value in 2022 USD 10.32 Billion
Market size value in 2030 USD 22.62 Billion
CAGR (2022 to 2030) 10.31%
Historical data 2019-2020
Base Year 2021
Forecast 2022-2030
Segments The research segment is based on product type, route of administration, and distribution channel.
Regional Segments The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the atopic dermatitis market was valued at USD 10.32 billion in 2022 to USD 22.62 billion by 2030.

Global atopic dermatitis market is growing at a CAGR of 10.31% during the forecast period 2022-2030.

The market's growth will be influenced by the growing incidence of skin disorders.

Inadequate understanding of the causes of atopic dermatitis could hamper the market growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Route of Administration
          4.3.3. Market Attractiveness Analysis by Distribution Channel
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The growing incidence of skin disorders
    5.3. Restraints
          5.3.1. Inadequate understanding of the causes of atopic dermatitis
    5.4. Opportunities
          5.4.1. Novel biologics and advanced treatment options are being developed by market players
    5.5. Challenges
          5.5.1. Stringent regulatory approvals and guidelines

6. Global Atopic Dermatitis Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Corticosteroids
    6.3. Calcineurin Inhibitors
    6.4. Emollients/Moisturizers
    6.5. Antibiotics
    6.6. IL-4 and PDE4 Inhibitors
    6.7. Others

7. Global Atopic Dermatitis Market Analysis and Forecast, By Route of Administration
    7.1. Segment Overview
    7.2. Oral
    7.3. Topical
    7.4. Parenteral

8. Global Atopic Dermatitis Market Analysis and Forecast, By Distribution Channel
    8.1. Segment Overview
    8.2. Hospital Pharmacies
    8.3. Online Pharmacies
    8.4. Retail Pharmacies
    8.5. Others

9. Global Atopic Dermatitis Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Atopic Dermatitis Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Atopic Dermatitis Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. AbbVie Inc.
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Allergan Plc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Astellas Pharma Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Bristol -Myer Squibb
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Eli Lily and Company
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Galderma Laboratories LP
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Novartis Pharmaceuticals Corporation
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Pfizer
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Regeneron Pharmaceuticals Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Sanofi SA
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1. Global Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

2. Global Corticosteroids Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

3. Global Calcineurin Inhibitors Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

4. Global Emollients/Moisturizers Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

5. Global Antibiotics Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

6. Global IL-4 and PDE4 Inhibitors Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

7. Global Others Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

8. Global Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

9. Global Oral Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

10. Global Topical Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

11. Global Parenteral Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

12. Global Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

13. Global Hospital Pharmacies Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

14. Global Online Pharmacies Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

15. Global Retail Pharmacies Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

16. Global Others Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

17. Atopic Dermatitis Market, By Region, 2019-2030 (USD Billion) 

18. North America Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

19. North America Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

20. North America Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

21. U.S. Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

22. U.S. Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

23. U.S. Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

24. Canada Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

25. Canada Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

26. Canada Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

27. Mexico Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

28. Mexico Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

29. Mexico Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

30. Europe Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

31. Europe Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

32. Europe Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

33. Germany Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

34. Germany Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

35. Germany Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

36. France Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

37. France Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

38. France Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

39. U.K. Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

40. U.K. Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

41. U.K. Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

42. Italy Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

43. Italy Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

44. Italy Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

45. Spain Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

46. Spain Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

47. Spain Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

48. Asia Pacific Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

49. Asia Pacific Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

50. Asia Pacific Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

51. Japan Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

52. Japan Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

53. Japan Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

54. China Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

55. China Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

56. China Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

57. India Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

58. India Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

59. India Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

60. South America Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

61. South America Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

62. South America Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

63. Brazil Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

64. Brazil Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

65. Brazil Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

66. Middle East and Africa Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

67. Middle East and Africa Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

68. Middle East and Africa Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

69. UAE Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

70. UAE Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

71. UAE Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

72. South Africa Atopic Dermatitis Market, By Product Type, 2019-2030 (USD Billion) 

73. South Africa Atopic Dermatitis Market, By Route of Administration, 2019-2030 (USD Billion) 

74. South Africa Atopic Dermatitis Market, By Distribution Channel, 2019-2030 (USD Billion) 

List of Figures 

1. Global Atopic Dermatitis Market Segmentation

2. Atopic Dermatitis Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Atopic Dermatitis Market Attractiveness Analysis by Product Type

9. Global Atopic Dermatitis Market Attractiveness Analysis by Route of Administration

10. Global Atopic Dermatitis Market Attractiveness Analysis by Distribution Channel

11. Global Atopic Dermatitis Market Attractiveness Analysis by Region

12. Global Atopic Dermatitis Market: Dynamics

13. Global Atopic Dermatitis Market Share by Product Type (2022 & 2030)

14. Global Atopic Dermatitis Market Share by Route of Administration (2022 & 2030)

15. Global Atopic Dermatitis Market Share by Distribution Channel (2022 & 2030)

16. Global Atopic Dermatitis Market Share by Regions (2022 & 2030)

17. Global Atopic Dermatitis Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the atopic dermatitis market based on below mentioned segments:

Atopic Dermatitis Market by Product Type:

  • Corticosteroids
  • Calcineurin Inhibitors
  • Emollients/Moisturizers
  • Antibiotics
  • IL-4 and PDE4 Inhibitors
  • Others

Atopic Dermatitis Market by Route of Administration:

  • Oral
  • Topical
  • Parenteral

Atopic Dermatitis Market by Distribution Channel:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others

Atopic Dermatitis Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date